David Lee

Dr. David Lee is the newest addition to the Applied StemCell team. With over 20 years of stem cell and natural killer cell GMP and quality experience, he will lead the new GMP and Quality sector at ASC. Dr. Lee received his Ph.D. in genetics from the University of California, Riverside and completed his post-doctoral research at Case Western Reserve University on cell and gene therapy and mammary tumor and prostate cancer regression. Dr. Lee has contributed to several patent registrations and applications as well as 30 scientific papers. After beginning his bio-industrial career as a Senior Scientist at Osiris Therapeutics, Dr. Lee continued his profession as the Chief Operating Officer and Director of Molecular Biology of PlantVax, Inc. and the Chief Scientific Officer of Human Biostar, Inc. Prior to joining ASC, Dr. Lee served as the Head of Bio Strategy and Officer of Cell Therapy Quality at LORDS Co., Ltd. Dr. David Lee has led several R&D teams in cell therapy development projects, helped build cleanrooms and GMP facilities, and has even supervised the GMP manufacturing process. With his comprehensive understanding of industry-level cell therapy product development and GMP manufacturing, Dr. Lee is on a mission to expand ASC’s GMP iPSC-derived product development and manufacturing capabilities to help ASC become a top CRO/CDMO in the biotechnology industry.